Co-Diagnostics Receivables 2017-2025 | CODX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics receivables from 2017 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics receivables from 2017 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$136B
CVS Health (CVS)	$78.4B
Elevance Health (ELV)	$62.4B
Cencora (COR)	$56.8B
DiDi Global (DIDIY)	$26.9B
Labcorp Holdings (LH)	$20.4B
Natera (NTRA)	$19B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$14B
CochLear (CHEOY)	$13.1B
Solventum (SOLV)	$12.7B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11B
Viatris (VTRS)	$10.4B
Avantor (AVTR)	$9.1B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$7.7B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.1B
Surgery Partners (SGRY)	$2.9B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
Alignment Healthcare (ALHC)	$2.5B
GeneDx Holdings (WGS)	$2.2B
Progyny (PGNY)	$1.9B